Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilmar Reis

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
The Lancet. Global Health|April 18, 2021
How COVID-19 has fundamentally changed clinical research in global healthJay J H Park, Robin Mogg, Gerald E Smith, et al.
The American Journal of Tropical Medicine and Hygiene|August 24, 2020
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19Craig R Rayner, Louis Dron, Jay J H Park, et al.
The American Journal of Tropical Medicine and Hygiene|November 14, 2022
Toward a New Paradigm of North-South and South-South Partnerships for Pandemic Preparedness: Lessons Learned from COVID-19 and Other OutbreaksSabin Nsanzimana, Angeli Rawat, Lindsay A Wilson, et al.
International Journal of Cardiology|April 16, 2013
Percutaneous revascularization and long term clinical outcomes of diabetic patients randomized in the Occluded Artery Trial (OAT)Christopher B Overgaard, Vladimír Džavík, Christopher E Buller, et al.
JAMA Network Open|May 20, 2024
Matched vs Nonmatched Placebos in a Randomized Trial of COVID-19 TreatmentsGilmar Reis, Leonardo Cançado Monteiro Savassi, Thiago Santiago Ferreira, et al.
Contemporary Clinical Trials|June 7, 2021
Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: A study within a trialDavid Collister, Lawrence Mbuagbaw, Gordon Guyatt, et al.
Circulation. Heart Failure|August 15, 2014
Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) TrialAmil M Shah, Brian Claggett, Nancy K Sweitzer, et al.
JAMA Network Open|April 22, 2021
Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical TrialGilmar Reis, Eduardo Augusto Dos Santos Moreira Silva, Daniela Carla Medeiros Silva, et al.
Clinical and Translational Science|January 5, 2023
Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trialsOriol Mitjà, Gilmar Reis, David R Boulware, et al.
Lancet Regional Health. Americas|December 20, 2021
Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trialGilmar Reis, Eduardo Augusto Dos Santos Moreira Silva, Daniela Carla Medeiros Silva, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
The Lancet. Global Health|April 18, 2021
How COVID-19 has fundamentally changed clinical research in global healthJay J H Park, Robin Mogg, Gerald E Smith, et al.
The American Journal of Tropical Medicine and Hygiene|August 24, 2020
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19Craig R Rayner, Louis Dron, Jay J H Park, et al.
The American Journal of Tropical Medicine and Hygiene|November 14, 2022
Toward a New Paradigm of North-South and South-South Partnerships for Pandemic Preparedness: Lessons Learned from COVID-19 and Other OutbreaksSabin Nsanzimana, Angeli Rawat, Lindsay A Wilson, et al.
International Journal of Cardiology|April 16, 2013
Percutaneous revascularization and long term clinical outcomes of diabetic patients randomized in the Occluded Artery Trial (OAT)Christopher B Overgaard, Vladimír Džavík, Christopher E Buller, et al.
JAMA Network Open|May 20, 2024
Matched vs Nonmatched Placebos in a Randomized Trial of COVID-19 TreatmentsGilmar Reis, Leonardo Cançado Monteiro Savassi, Thiago Santiago Ferreira, et al.
Contemporary Clinical Trials|June 7, 2021
Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: A study within a trialDavid Collister, Lawrence Mbuagbaw, Gordon Guyatt, et al.
Circulation. Heart Failure|August 15, 2014
Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) TrialAmil M Shah, Brian Claggett, Nancy K Sweitzer, et al.
JAMA Network Open|April 22, 2021
Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical TrialGilmar Reis, Eduardo Augusto Dos Santos Moreira Silva, Daniela Carla Medeiros Silva, et al.
Clinical and Translational Science|January 5, 2023
Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trialsOriol Mitjà, Gilmar Reis, David R Boulware, et al.
Lancet Regional Health. Americas|December 20, 2021
Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trialGilmar Reis, Eduardo Augusto Dos Santos Moreira Silva, Daniela Carla Medeiros Silva, et al.
Pageof 3